Slide 1Subgroup Analyses: Can We Smooth' out the Rough Edges? Daniel Sargent, PhD Mayo Clinic Sept 28, 2006 Slide 2 Outline Motivation Motivation Subgroups ARE medicine…

1.This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Intensity-modulated…

1. Juliet N. Barker, MBBS (Hons), FRACP Associate Attending Director, Cord Blood Transplant Program Memorial Sloan-Kettering Cancer Center Double Unit Cord Blood Transplantation…

PowerPoint Presentation RAYMOND WONG, MD Hong Kong Consultant of the Department of Medicine & Therapeutics, Prince of Wales Hospital Dr. Wong received his medical degree…

Images are not actual patients.Dr. Gladwell G KiarieMedical OncologistSenior Lecturer University of NairobiImages are not actual patients.Nairobi Cancer Registry, KEMRICervix…

1. Powered by 2. A clinical trial design is the blueprint for its eventual success. 3. Where are we today? East is the industry standard for designing adequate and well-controlled…

1. VIKRAM MATHEWS, MD CMC, Vellore, India  Professor & Chair, Department of Hematology, Christian Medical College, Vellore, India  Dr. Matthews is leading hematologist…

Slide 1 Stem cells and cancer: treatment resistance and novel therapeutic targets Rob Clarke Manchester, UK Q-CROC, Montreal, 6 th November, 2010 Cancer Slide 2 Potential…

Slide 1 A Report from ASCO 2007 Adjuvant Colorectal Cancer John L. Marshall, MD Chief, Division of Hematology/Oncology Associate Director of Clinical Research Director, Developmental…

Slide 1 Upper Gastrointestinal Overview 2007- 2008: Practical Implications of the Newest Data Esophageal and Gastric Cancers Johanna Bendell, MD Sarah Cannon Research Institute…